Staphylococcus aureus surgical site infection rates in 5 European countries

Table 3 Factors affecting likelihood of SA SSI (Logistic regression)

Factor	Pearson Chi-Square	Odds ratio (95% confidence interval)
Cardiovascular
Chronic CVD	< 0.001	1.9 (1.3–2.6)
Congestive HF	0.730	1.8 (0.9–3.5)
Peripheral VD	< 0.001	2.7 (2.0–3.7)
Pulmonal
COPD	0.108	1.6 (0.9–23.0)
Cancer
Leukaemia	0.397	0.995 (0.995–0.996)
Lymphoma	0.001	3.9 (1.6–9.4)
Solid tumour	< 0.001	2.1 (1.6–2.8)
Neurological
Dementia	0.673	1.4 (0.3–5.4)
TIA or CVA	0.619	1.6 (0.2–11.8)
Hemiplegia	0.061	1.9 (1.0–3.9)
Other Internal
Diabetes	< 0.001	1.7 (1.4–2.1)
Liver diseases	0.102	1.7 (0.9–3.4)
CKD	0.010	1.7 (1.3–2.5)
HIV/AIDS	0.404	2.3 (0.3–16.3)

AIDS Acquired immunodeficiency disease, CVA Cerebral vascular accident, CKD Chronic kidney disease, CVD Chronic cardiovascular diseases, HIV Human immunodeficiency virus, HF Heart failure, SA Staphylococcus aureus, SSI Surgical site infection, VD Vascular diseases, TIA Transient ischemic attack

ISSN: 2047-2994